Browsing by Author Raal, FJ

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 26  next >
Issue DateTitleAuthor(s)
1-May-2021A meta-analysis of medications directed against PCSK9 in familial hypercholesterolemiaBrandts, J; Dharmayat, KI; Vallejo-Vaz, AJ; Azar Sharabiani, MT; Jones, R, et al
14-Jul-2018Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataractMach, F; Ray, KK; Wiklund, O; Corsini, A; Catapano, AL, et al
1-Dec-2020Characteristics of adults with heterozygous familial hypercholesterolaemia stratified by gender: preliminary analysis from the eas fhsc global registry on over 36,000 cases of familial hypercholesterolaemiaVallejo-Vaz, AJ; Dharmayat, K; Stevens, C; Lyons, A; Brandts, J, et al
27-May-2016Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia PanelSantos, RD; Gidding, SS; Hegele, RA; Cuchel, MA; Barter, PJ, et al
Jun-2023Efficacy and safety of inclisiran in patients with cerebrovascular disease: ORION-9, ORION-10, and ORION-11Koenig, W; Ray, KK; Landmesser, U; Leiter, LA; Schwartz, GG, et al
25-May-2015Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatmentWiegman, A; Gidding, SS; Watts, GF; Chapman, MJ; Ginsberg, HN, et al
15-Aug-2013Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart diseaseNordestgaard, BG; Chapman, MJ; Humphries, SE; Ginsberg, HN; Masana, L, et al
18-Sep-2015Familial hypercholesterolaemia: a global call to armsVallejo-Vaz, AJ; Seshasai, SRK; Della, C; Hovingh, GK; Kastelein, JJP, et al
1-Jun-2020Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of careWatts, GF; Gidding, SS; Mata, P; Pang, J; Sullivan, DR, et al
6-Nov-2021Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)Vallejo-Vaz, AJ; Stevens, CAT; Lyons, ARM; Dharmayat, KI; Freiberger, T, et al
Aug-2022Global perspective of paediatric Familial Hypercholesterolaemia: Analysis from the EAS FHSC registry on over 11,200 children and adolescents with heterozygous Familial Hypercholesterolaemia from 44 countriesDharmayat, KI; Vallejo-Vaz, AJ; Stevens, CA; Lyons, AR; Catapano, AL, et al
1-Dec-2020Heterozygous familial hypercholesterolaemia in children: preliminary analysis from the eas fhsc global registry on over 7,900 children with familial hypercholesterolaemiaDharmayat, K; Stevens, C; Lyons, A; Catapano, AL; Freiberger, T, et al
22-Jul-2014Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis SocietyCuchel, M; Bruckert, E; Ginsberg, HN; Raal, FJ; Santos, RD, et al
1-Aug-2022Identification, characteristics and management of adults with heterozygous Familial Hypercholesterolaemia in high and non-high income countries participating in the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)Vallejo-Vaz, A; Stevens, C; Dharmayat, K; Lyons, A; Brandts, J, et al
16-Apr-2020Inclisiran for the treatment of heterozygous familial hypercholesterolemiaRaal, FJ; Kallend, D; Ray, KK; Turner, T; Koenig, W, et al
1-Dec-2023International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemiaWatts, GF; Gidding, SS; Hegele, RA; Raal, FJ; Sturm, AC, et al
24-Apr-2017Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic and clinical studies A Consensus Statement from the European Atherosclerosis Society Consensus PanelFerence, BA; Ginsberg, HN; Graham, I; Ray, KK; Packard, CJ, et al
Jun-2020Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus PanelBorén, J; Chapman, MJ; Krauss, RM; Packard, CJ; Bentzon, JF, et al
1-Oct-2018Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)Vallejo-Vaz, AJ; De Marco, M; Stevens, CAT; Akram, A; Freiberger, T, et al
7-Dec-2016Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: rationale and design of the global EAS Familial Hypercholesterolaemia Studies CollaborationVallejo-Vaz, A; Akram,, A; Seshasai,, R; Cole,, D; Watts, GF, et al